Clonz Biotech offers mammalian and microbial pharmaceutical R&D services with cGMP-enabling processes. Services include mammalian cell line development, microbial strain development through a well planned genetic engineering for efficient process advantages. Key areas include research cell bank production, process development, process optimization using statistical Design-of-Experiments (DoE), technology transfer, scaled-down model development and process characterization using a QbD framework.
Clonz Bio R&D uses the latest equipment available. Most of the equipment is under two years old, even though as a company we were founded over ten years ago.
The R&D facility has the following key departments:
Want to know more about any of our products or services? Simply fill out the contact form and one of our team members will respond to you shortly.